# Chapter 68. Translation Elongation, Fidelity, Pausing, and Cotranslational Folding

## Scope Note

Translation elongation is the repeated ribosomal cycle that reads messenger RNA codons after initiation and before termination. This chapter treats elongation as a coupled RNA-centered process: codons are decoded by transfer RNAs, ribosomal RNA provides the core catalytic and conformational framework, elongation factors use guanosine triphosphate hydrolysis to drive directionality and accuracy, messenger RNA sequence and structure shape local speed, and nascent polypeptides begin folding and targeting while still attached to peptidyl-transfer RNA. The chapter emphasizes causal mechanisms, evidence standards, and the limits of interpreting elongation-rate measurements.

## Executive Summary

Translation elongation converts codon order in an mRNA into amino acid order in a protein. Each elongation cycle begins with a ribosome carrying peptidyl-tRNA in the P site and an empty A site positioned over the next codon. An elongation factor delivers an aminoacyl-tRNA to the A site as a ternary complex with guanosine triphosphate (GTP). Correct codon-anticodon pairing promotes ribosomal conformational changes, GTP hydrolysis, factor release, accommodation of the aminoacyl-tRNA into the peptidyl transferase center, peptide-bond formation, hybrid tRNA states, and translocation of the mRNA-tRNA complex by one codon. In bacteria, the main factors are EF-Tu and EF-G; in eukaryotes, the homologous factors are eEF1A and eEF2. Archaeal and organellar systems use related but specialized factors.

Fidelity is not a single checkpoint. Aminoacyl-tRNA synthetases establish the first major accuracy layer by matching amino acids to tRNAs, while the ribosome establishes a second layer by discriminating among codon-anticodon interactions. Ribosomal decoding uses induced fit, kinetic partitioning, initial selection before GTP hydrolysis, and proofreading after GTP hydrolysis to reject many near-cognate tRNAs. This discrimination is powerful but not absolute. Mistranslation can increase during stress, under amino acid limitation, during antibiotic exposure, or when tRNA modification and charging systems are perturbed. Some mistranslation is damaging; some can be tolerated or even used as a stress-buffering strategy, but broad claims of adaptive mistranslation require direct evidence rather than correlations.

Elongation speed varies along mRNAs. Local rate can be influenced by codon identity, tRNA availability and charging, wobble decoding, mRNA secondary structure, nascent peptide-ribosome interactions, polybasic tracts, ribosome traffic, amino acid availability, and regulatory factors. A "pause" is a local kinetic delay relative to neighboring codons, whereas "ramping" refers to systematic slower elongation near the beginning of coding sequences. Ramping has been proposed to reduce ribosome collisions and coordinate protein biogenesis, but its interpretation depends strongly on measurement method, gene expression level, initiation rate, and species context. Codon-dependent dynamics also connect translation to mRNA stability because slow or collided ribosomes can recruit decay and quality-control pathways.

Cotranslational folding begins before a protein is released. The nascent chain exits through a ribosomal tunnel that permits early helix formation and can communicate sequence-dependent signals to the peptidyl transferase center. Outside the tunnel, domains may fold vectorially from the N terminus to the C terminus, bind chaperones, assemble with partner proteins, or be recognized by targeting factors. The signal recognition particle is a central example: a hydrophobic signal sequence emerging from a translating ribosome can recruit SRP, pause or modulate elongation, and route the ribosome-nascent-chain complex to a membrane translocon. Cotranslational folding is therefore not only a property of proteins; it is a property of the mRNA-ribosome-nascent-chain system.

Antibiotics, toxins, stress pathways, and nutrient limitation reveal elongation mechanisms by perturbing them. Aminoglycosides can reduce decoding accuracy in bacteria; macrolides and related drugs can obstruct or allosterically alter the exit tunnel; cycloheximide inhibits eukaryotic elongation and is often used experimentally; diphtheria toxin and related toxins modify eEF2. Stress changes translation through factor phosphorylation, tRNA charging, ribosome rescue, integrated stress response pathways, and altered mRNA selection. However, drug-treated ribosome footprints are not neutral snapshots of normal elongation, and stress-induced footprint changes can reflect initiation, elongation, ribosome collision, decay, and extraction effects simultaneously.

Modern measurement has transformed elongation biology but also created interpretation hazards. Ribosome profiling counts protected mRNA fragments to infer ribosome positions genome-wide, but footprint density is shaped by initiation, elongation, lysis, inhibitors, nuclease digestion, mapping, and normalization. Single-molecule approaches can watch conformational transitions and factor binding directly, but they often use simplified mRNAs, purified components, or surface-tethered systems. Structural methods capture ribosomal states at high resolution, but static structures must be embedded in kinetic models. Strong claims about elongation dynamics are most convincing when multiple evidence types converge.

## Concept Inventory

- **Elongation cycle:** The repeated sequence of aminoacyl-tRNA selection, peptide-bond formation, and translocation that lengthens the nascent polypeptide by one amino acid per codon.
- **A, P, and E sites:** The ribosomal aminoacyl, peptidyl, and exit tRNA-binding sites. The A site accepts incoming aminoacyl-tRNA, the P site holds peptidyl-tRNA before peptide transfer, and the E site transiently binds deacylated tRNA before release.
- **Aminoacyl-tRNA:** A tRNA esterified to its cognate amino acid by an aminoacyl-tRNA synthetase. The amino acid is attached to the 3′ end of the tRNA.
- **Peptidyl-tRNA:** A tRNA linked to the growing peptide chain. During elongation, peptidyl-tRNA normally occupies the P site before peptide-bond formation and the A site immediately after peptide-bond formation.
- **Ternary complex:** In translation elongation, the complex of elongation factor, GTP, and aminoacyl-tRNA that delivers the tRNA to the ribosome.
- **Accommodation:** Movement of an aminoacyl-tRNA acceptor end into the peptidyl transferase center after successful decoding and factor release.
- **Translocation:** Movement of the mRNA-tRNA complex by one codon, placing the newly formed peptidyl-tRNA in the P site and opening the A site for the next codon.
- **Ribosomal ratcheting:** A relative rotation between ribosomal subunits associated with hybrid tRNA states and translocation.
- **Decoding fidelity:** The accuracy with which the ribosome selects tRNAs that match mRNA codons according to the genetic code.
- **Proofreading:** A kinetic discrimination step after GTP hydrolysis that allows incorrect or near-cognate tRNAs to dissociate before peptide-bond formation.
- **Cognate, near-cognate, and non-cognate tRNAs:** Cognate tRNAs match a codon according to accepted decoding rules; near-cognate tRNAs differ by one or otherwise partially compatible base pair; non-cognate tRNAs lack productive codon-anticodon pairing.
- **Ribosome pause:** A local delay in elongation. A pause is not automatically regulatory; it may result from chemistry, codon usage, mRNA structure, nascent-chain interactions, ribosome traffic, stress, or technical bias.
- **Codon ramp:** A region, often near the 5′ end of coding sequences, where translation is proposed to proceed more slowly than downstream regions.
- **Cotranslational folding:** Folding of a nascent polypeptide while it remains attached to tRNA in a translating ribosome.
- **Ribosome-nascent-chain complex:** A translating ribosome together with its bound mRNA, peptidyl-tRNA, and emerging polypeptide.
- **Signal recognition particle:** An RNA-protein ribonucleoprotein that recognizes signal sequences on nascent chains and targets ribosome-nascent-chain complexes to membranes.

## What to Know Before Reading This Chapter

This chapter assumes the reader knows that protein-coding mRNAs are read in triplet codons from 5′ to 3′ and that amino acids are brought to the ribosome by tRNAs. [Chapter 66](chapter1061.md) explains the genetic code, codon degeneracy, wobble, tRNA pools, and codon optimality. [Chapter 67](chapter1062.md) explains how a ribosome is placed at the start codon. [Chapter 69](chapter1064.md) covers stop-codon recognition, termination, recycling, frameshifting, and readthrough. [Chapter 70](chapter1065.md) covers ribosome quality-control pathways that respond to stalled, collided, or damaged translation complexes.

The central running example is a cytosolic mRNA being translated by many ribosomes. One ribosome has already initiated and sits with a peptidyl-tRNA in the P site. The next mRNA codon is exposed in the A site. A pool of aminoacyl-tRNAs competes to enter the A site, and only some tRNAs carry anticodons compatible with that codon. The ribosome must select the right tRNA quickly enough to support efficient protein synthesis and accurately enough to preserve protein sequence. As the ribosome moves, the growing peptide exits through a tunnel and begins encountering the cellular folding and targeting environment.

Two boundaries are important. First, "translation rate" can mean several different quantities: peptide-bond formation rate at one codon, average elongation rate across a gene, ribosome density on an mRNA, protein output per mRNA, or ribosome transit time from start to stop. These quantities are related but not interchangeable. Second, a ribosome footprint is an experimental measurement, not a direct photograph of an elongation rate. A footprint peak can indicate a slow step, but it can also arise from initiation differences, collisions, nuclease bias, inhibitor artifacts, mapping ambiguity, or selective ribosome protection.

## 68.1. Elongation factors and ribosomal states

Translation elongation is easiest to understand as a cycle of states rather than as a linear list of factors. At the start of a typical elongation cycle, the ribosome has a peptidyl-tRNA in the P site and an empty A site. The mRNA codon in the A site is exposed to the cytosolic pool of aminoacyl-tRNAs. In bacteria, EF-Tu bound to GTP carries an aminoacyl-tRNA to this site. In eukaryotes, eEF1A-GTP performs the analogous delivery reaction. The factor protects the ester linkage between the amino acid and tRNA, positions the tRNA for initial codon inspection, and couples successful decoding to GTP hydrolysis.

![Figure 68.1. The Elongation Cycle as a Ribosomal State Machine](../assets/figures/chapter1063_figure1.png)

**Figure 68.1. The Elongation Cycle as a Ribosomal State Machine.** A translating ribosome begins each elongation cycle with peptidyl-tRNA in the P site and an empty A site. In bacteria, EF-Tu·GTP delivers aminoacyl-tRNA to the A site; in eukaryotes, the analogous carrier is eEF1A·GTP. Correct codon–anticodon pairing activates GTP hydrolysis and factor release, the aminoacyl-tRNA accommodates into the peptidyl transferase center, peptide-bond formation extends the nascent chain, tRNAs shift into hybrid states, and EF-G or eEF2 drives translocation by one codon to reset the A site for the next cycle.

![Figure 68.2. Fidelity Checkpoints in Translation](../assets/figures/chapter1063_figure2.png)

**Figure 68.2. Fidelity Checkpoints in Translation.** Fidelity in translation is layered across multiple sequential checkpoints. Aminoacyl-tRNA synthetases establish accuracy at the charging step by matching each tRNA to its cognate amino acid, and many synthetases possess editing activities that hydrolyze misactivated amino acids or mischarged tRNAs. During decoding, the ribosome applies initial selection before GTP hydrolysis and proofreading after GTP hydrolysis but before peptide-bond formation, together rejecting the large majority of non-cognate and near-cognate tRNAs. Mischarged tRNAs bypass ribosomal discrimination because the ribosome reads the anticodon rather than the attached amino acid, which separates charging fidelity from decoding fidelity and defines the limits of each layer.

![Figure 68.3. Mechanisms That Produce Ribosome Pauses](../assets/figures/chapter1063_figure3.png)

**Figure 68.3. Mechanisms That Produce Ribosome Pauses.** A local ribosome footprint peak can arise from multiple distinct mechanisms: scarce or poorly charged cognate tRNA, kinetically disfavored wobble decoding, mRNA secondary structure ahead of the A site, nascent peptide interactions with the exit tunnel, polybasic tracts, ribosome queuing behind a slow site, collision with a trailing ribosome, antibiotic treatment, cellular stress, nuclease digestion bias, or read-mapping ambiguity. Not all peaks reflect regulatory pauses, and distinguishing biological causes from experimental artifacts requires perturbation experiments and orthogonal controls.

**Table 68.1. Translation Elongation Inhibitors and Interpretation Caveats.** Common translation elongation inhibitors and experimental toxins, organized by their molecular target, organismal selectivity, typical experimental application, and the main caveat for interpreting ribosome footprint data collected in their presence.

| Perturbation | Primary target or step | Main organismal selectivity | Typical experimental use | Caveat for interpreting ribosome footprints |
| --- | --- | --- | --- | --- |
| **Aminoglycosides** | A-site decoding accuracy | Bacteria; some mitochondrial effect | Induce misreading; study decoding fidelity | Promote near-cognate tRNA accommodation; footprints at affected codons do not reflect natural dwell times |
| **Tetracyclines** | Aminoacyl-tRNA entry to A site | Bacteria | Block tRNA delivery; deplete ribosome density | Prevent forward elongation; produce ribosome runoff rather than stable pause sites |
| **Macrolides** | Nascent peptide exit tunnel | Bacteria | Study tunnel-dependent pausing; used in some profiling lysis buffers | Enrich ribosomes near the 5′ coding region; bias footprint density away from downstream positions |
| **Chloramphenicol** | Peptidyl transferase center; peptide-bond formation | Bacteria | Freeze ribosome positions for profiling | Locks pre-peptide-bond state; ribosome register may differ from mid-cycle translocation states |
| **Fusidic acid** | EF-G·GDP; post-hydrolysis translocation step | Bacteria | Trap post-translocation EF-G–ribosome complex | Stabilizes factor-bound post-translocation conformation; footprint positions are not steady-state elongation sites |
| **Cycloheximide** | eEF2-mediated translocation | Eukaryotic cytosol | Standard ribosome-freezing agent for ribosome profiling | Shifts ribosome register relative to the A site; alters apparent codon occupancy and footprint 5′-edge position |
| **Emetine** | 40S subunit; translocation block | Eukaryotic cytosol | Alternative freeze agent preferred in some protocols | Produces different footprint length distribution than cycloheximide; captured ribosome conformation differs |
| **Puromycin** | Aminoacyl-tRNA mimic; premature peptide release | Bacteria and eukaryotes | Terminate nascent chains; measure translational capacity | Causes ribosome runoff; not appropriate for steady-state elongation footprint mapping |
| **Diphtheria toxin** | eEF2 via ADP-ribosylation; translocation block | Eukaryotes | Study eEF2 function and translocation mechanism | Blocks translocation; accumulates ribosomes in pre-translocation states; not useful for natural elongation maps |

The ribosome itself is an RNA-rich molecular machine. The small ribosomal subunit organizes the decoding center, where the mRNA codon and tRNA anticodon are monitored. The large ribosomal subunit contains the peptidyl transferase center, which is formed primarily by rRNA and catalyzes peptide-bond formation. Ribosomal proteins stabilize the architecture, tune dynamics, and create binding surfaces for factors and nascent-chain partners, but the most ancient catalytic and decoding framework is ribonucleoprotein rather than a purely protein enzyme. Structural studies reviewed by Korostelev emphasize that elongation requires coordinated motions of the small subunit, large subunit, tRNAs, mRNA, and GTPase factors rather than simple rigid-body movement.

When a cognate ternary complex samples the A site, codon-anticodon pairing in the decoding center promotes a closed small-subunit conformation. This induced-fit state stimulates GTPase activation on EF-Tu or eEF1A. After GTP hydrolysis, the elongation factor dissociates, and the aminoacyl-tRNA must accommodate. Accommodation means that the tRNA acceptor stem swings into the peptidyl transferase center while the anticodon remains paired to the mRNA. This movement is not trivial: a near-cognate tRNA may pass initial selection but fail during accommodation, dissociating before peptide-bond formation.

Peptide-bond formation transfers the nascent peptide from the P-site tRNA to the amino group of the A-site aminoacyl-tRNA. The product is a longer peptidyl-tRNA in the A site and a deacylated tRNA in the P site. The ribosome then fluctuates into hybrid states: the acceptor ends of the tRNAs move relative to the large subunit before the anticodon ends fully move relative to the small subunit. The small and large subunits rotate relative to each other in a motion often called ratcheting. EF-G in bacteria or eEF2 in eukaryotes binds and hydrolyzes GTP to promote translocation. Translocation moves the mRNA by one codon, shifts peptidyl-tRNA into the P site, moves deacylated tRNA toward the E site, and resets the A site.

This cycle has conserved logic across life, but its molecular implementation varies. Bacteria, archaea, eukaryotic cytosol, mitochondria, and chloroplasts use homologous or analogous elongation factors with lineage-specific adaptations. Mitochondrial ribosomes, for example, have altered RNA-protein composition and specialized factor requirements. Bacterial ribosomes are major antibiotic targets because bacterial elongation factors, rRNA structures, and exit-tunnel interactions differ enough from eukaryotic cytosolic translation to allow selective inhibition, although toxicity can arise when mitochondrial translation is affected.

The evidence for these states comes from converging methods. Cryo-EM and crystallography provide structural snapshots of tRNA positions, factor binding, and subunit rotations. Rapid kinetics and fluorescence experiments measure the timing of GTP hydrolysis, accommodation, peptide-bond formation, and translocation. Single-molecule FRET observes subunit ratcheting and tRNA transitions in real time. Ribosome profiling and biochemical run-off assays infer elongation behavior in cells. No method alone supplies the complete cycle: structural states need kinetic ordering, and kinetic rates need structural assignments.

**Table 68.2. Evidence Types for Elongation-Rate Claims.** Major experimental approaches used to characterize translation elongation rates, listing what each method directly measures, what it permits inference about, its main strength, and a key artifact or limitation.

| Method | Directly measured quantity | Inferred quantity | Strength | Common artifact or limitation |
| --- | --- | --- | --- | --- |
| **Ribosome profiling** | Ribosome-protected mRNA fragment density | Relative ribosome occupancy; translated ORFs; approximate pausing | Genome-wide coverage; unbiased ORF discovery | Density reflects initiation, elongation, and collisions simultaneously; inhibitor treatment distorts positions |
| **Run-off ribosome profiling** | Ribosome clearance from coding regions over time after initiation block | Elongation transit time; average codon dwell time | Direct temporal measurement of bulk elongation rate | Requires complete initiation block; estimates average rate, not individual codon resolution |
| **Disome profiling** | mRNA fragments protected by two adjacent ribosomes | Ribosome collision sites; stalling frequency | Maps collision-prone pause sites genome-wide | Enriches rare events; very brief stalls may be missed; lysis conditions can disrupt collided disomes |
| **Reporter assays** | Reporter protein level or fluorescence from codon-variant constructs | Relative elongation efficiency for specific codon sequences | Accessible; scalable; compatible with genetic screens | Reporter context may not reflect endogenous mRNAs; conflates elongation, initiation, and mRNA stability effects |
| **Mass spectrometry for mistranslation** | Amino acid substitutions detected in tryptic peptides | Misincorporation frequency at specific codons | Direct amino acid–level error detection | Requires abundant, well-resolved peptides; unstable mistranslated proteins are undersampled |
| **Rapid kinetic reconstitution** | Pre-steady-state fluorescence or puromycin reactivity with purified components | Rate constants for accommodation, peptide-bond formation, and translocation | Mechanistic resolution of individual substep rate constants | Performed in simplified in vitro conditions; may not capture cellular tRNA pool complexity or chaperone context |
| **Single-molecule FRET** | Fluorescence distance changes between labeled ribosomal or tRNA molecules | Conformational transitions; stepwise kinetics; molecular heterogeneity | Reveals heterogeneity hidden in ensemble measurements | Fluorescent labels may perturb kinetics; surface tethering restricts conformational freedom; typically uses short model mRNAs |
| **Optical tweezers** | Mechanical force or extension of nascent chain or ribosome complex | Translocation force; cotranslational folding energy barriers | Force-resolution measurement of pause strength and folding | Very low throughput; non-physiological load application; ribosome or mRNA attachment is technically demanding |
| **Cryo-EM state classification** | Particle images sorted into structural conformational classes | Relative abundance of functional states; factor-bound or hybrid-state conformations | Atomic-resolution structural detail for each identified state | Sample preparation and vitrification bias class populations; class abundance does not directly report kinetic rate |

Do not overgeneralize from a single ribosomal state diagram. A textbook diagram often shows clean A, P, and E sites, but real ribosomes occupy ensembles of classical, hybrid, rotated, nonrotated, factor-bound, and factor-free states. The relative occupancy of these states changes with codon identity, tRNA abundance, nascent peptide sequence, antibiotics, magnesium concentration, and experimental system. [Chapter 69](chapter1064.md) extends the state-cycle logic to termination and recycling, where release factors and recycling factors remodel the same ribosomal framework.

## 68.2. Decoding fidelity and proofreading

Decoding fidelity is the probability that a codon is translated as the amino acid specified by the genetic code. The ribosome is not the first source of this accuracy. Aminoacyl-tRNA synthetases attach amino acids to tRNAs, and many synthetases have editing sites that hydrolyze misactivated amino acids or mischarged tRNAs. Once an amino acid is attached to a tRNA, the ribosome largely reads the tRNA anticodon rather than independently verifying the amino acid. A mischarged tRNA can therefore deliver the wrong amino acid efficiently if its anticodon matches the codon. This separation of tRNA charging fidelity from ribosomal decoding fidelity is essential for understanding suppressor tRNAs, genetic-code expansion, and mistranslation.

Ribosomal decoding discrimination begins when a ternary complex samples the A site. A cognate codon-anticodon helix fits the decoding center and promotes conformational changes in conserved small-subunit rRNA nucleotides. Near-cognate tRNAs may form two correct base pairs plus one mismatch, or otherwise create an imperfect helix that transiently resembles a cognate interaction. Non-cognate tRNAs usually dissociate rapidly. The challenge is that the ribosome must distinguish chemically similar RNA helices while operating fast enough to sustain growth. It solves this problem by kinetic partitioning rather than by a single equilibrium binding step.

Initial selection occurs before GTP hydrolysis. During this phase, incorrect tRNAs are more likely to dissociate before the elongation factor commits GTP. Correct pairing increases the probability that the ribosome activates the factor's GTPase center. Proofreading occurs after GTP hydrolysis and factor release but before peptide-bond formation. Because GTP hydrolysis is effectively irreversible under cellular conditions, the system can use energy expenditure to improve discrimination. A near-cognate tRNA that survived initial selection can still fail accommodation and leave the ribosome. These two selection windows multiply accuracy: each may discriminate modestly, but together they substantially lower error rates.

Accuracy depends on modifications and context. tRNA anticodon-loop modifications can improve reading-frame maintenance, stabilize or restrict wobble pairing, and tune decoding of specific codon families. rRNA modifications can influence decoding-center geometry. Aminoglycoside antibiotics in bacteria illustrate the fragility of this system because they can promote misreading by stabilizing conformations that resemble correct decoding. Conversely, hyperaccurate or error-prone ribosomal mutations have been used to dissect the relationship between ribosome dynamics and accuracy. Mohler and Ibba review how stress and mistranslation intersect, including cases where altered fidelity can be part of a broader cellular response rather than merely a passive defect.

The term "proofreading" should be used precisely. In DNA replication and some RNA virus polymerases, proofreading often means exonucleolytic removal of a wrongly incorporated nucleotide. In translation, ribosomal proofreading generally means rejection of an aminoacyl-tRNA after GTP hydrolysis but before peptide-bond formation; the ribosome does not cut out a wrong amino acid once it is incorporated into the growing peptide. After a mistranslation event, the resulting protein may misfold, be degraded, function poorly, or in some cases remain tolerated. Downstream quality control operates on proteins and ribosome states, not by reversing a peptide bond at the mistranslated codon.

Fidelity has measurable biological consequences. Low-level missense errors may be buffered by protein folding, redundancy, and degradation. Higher error rates can impair growth, trigger proteotoxic stress, alter immune antigen presentation, and produce dominant toxic proteins. In bacteria and fungi, environmental stress can alter mistranslation rates through tRNA charging, oxidative damage, antibiotic exposure, or regulated ambiguity. In eukaryotic cells, phosphorylation of eIF2alpha reduces initiation during stress, but elongation fidelity can also shift through tRNA availability, modification changes, and factor regulation. Evidence for adaptive mistranslation is strongest when experiments demonstrate both a reproducible error pattern and a causal fitness benefit.

![Figure 68.4. Cotranslational Folding and SRP Targeting](../assets/figures/chapter1063_figure4.png)

**Figure 68.4. Cotranslational Folding and SRP Targeting.** The nascent polypeptide emerges from the ribosomal exit tunnel while translation is still in progress, allowing N-terminal domains to begin folding before downstream sequence exists. Cytosolic chaperones, including trigger factor in bacteria and ribosome-associated complex in eukaryotes, can engage exposed segments as they emerge. When a hydrophobic signal sequence or transmembrane segment exits the tunnel, it can recruit the signal recognition particle, which targets the ribosome–nascent-chain complex to a membrane translocon through coordinated GTPase cycles between SRP and its receptor. Translation, cotranslational folding, and membrane targeting are therefore coupled events rather than sequential, independent steps.

Experimental evidence for decoding fidelity comes from several classes of assays. Reporter constructs can detect stop-codon readthrough, frameshifting, or missense suppression, but reporters may exaggerate or miss endogenous contexts. Mass spectrometry can identify amino acid substitutions in proteins, but detection sensitivity varies by peptide abundance and chemical properties. Ribosome biochemistry can measure near-cognate rejection rates with purified components. Genetic experiments can connect fidelity-altering mutations to phenotypes. A robust interpretation usually needs more than one assay, because a change in reporter output can reflect initiation, mRNA stability, protein stability, or stress responses rather than altered decoding alone.

## 68.3. Pausing, ramping, and codon-dependent dynamics

Elongation is not uniform. If every codon were translated at the same speed, ribosomes would move like identical beads on a track. In cells, elongation is instead a stochastic process with local delays and global constraints. A codon can be slow because its cognate aminoacyl-tRNA is scarce, because the tRNA is poorly charged, because wobble decoding is kinetically less favorable, because the mRNA folds into a structure that resists unwinding, because the nascent peptide interacts with the exit tunnel, or because a ribosome ahead has paused and caused traffic. The word "pause" therefore describes a kinetic observation, not a mechanism by itself.

Codon-dependent dynamics begin with the genetic code and tRNA pool. Synonymous codons can be decoded by different tRNAs or by the same tRNA through wobble pairing. In rapidly growing bacteria and many unicellular eukaryotes, highly expressed genes often use codons matched to abundant tRNAs. In multicellular eukaryotes, codon usage, tissue-specific tRNA expression, mRNA stability, and translational control are more context-dependent. Wu and Bazzini review the connection between translation and mRNA stability, including the idea that codon optimality can influence deadenylation and decay. [Chapter 66](chapter1061.md) treats codon optimality in detail; this chapter focuses on how codon identity is expressed as ribosome movement.

Codon ramping refers to the proposal that early coding regions often contain slower codons or slower elongation features. A ramp could reduce ribosome collisions by spacing ribosomes after initiation, provide time for early nascent-chain events, or reflect constraints on mRNA structure near the start codon. However, ramping is difficult to prove as an adaptation. The 5′ coding region is also shaped by initiation signals, nucleotide composition, mRNA secondary structure, protein targeting sequences, and amino acid composition. Ribosome profiling can show higher ribosome density near 5′ coding regions, but density may reflect initiation, early elongation, nuclease bias, or the geometry of footprints around start codons. A claim that ramping is selected for collision avoidance needs comparative, mechanistic, and perturbation evidence, not just a codon-usage gradient.

Programmed pauses are a special subset of pauses with evidence for function. Bacterial SecM is a classic example outside the current local bibliography and should be cited with a verified source in a later reference pass. SecM-like arrest peptides interact with the exit tunnel and regulate downstream gene expression by stalling translation. Other nascent peptides tune expression of antibiotic-resistance genes by responding to small molecules in the exit tunnel. Eukaryotic polybasic tracts can slow elongation and promote ribosome collisions, especially when positively charged residues interact with the negatively charged exit tunnel or when translation occurs under quality-control stress. These examples illustrate why the nascent chain is part of the elongation apparatus, not merely an output.

mRNA structure can slow elongation, but the effect is context-dependent. A stable stem-loop, pseudoknot, or G-quadruplex downstream of the A site may resist helicase-like unwinding by the ribosome. Viral programmed frameshifting signals often combine slippery sequences with downstream RNA structures, a topic treated in [Chapter 69](chapter1064.md). Cellular RNA structures can also shape elongation or ribosome loading, but structure-probing evidence, mutational rescue, and careful controls are required. A predicted stem-loop is not evidence of a pause by itself, and a footprint peak near a structured region does not prove that the structure caused the peak. The relevant evidence asks whether disrupting the structure changes ribosome dwell time while preserving coding potential and mRNA abundance.

Ribosome traffic creates another layer of dynamics. Translation initiation often controls how many ribosomes enter an mRNA. If initiation is high and a downstream elongation step is slow, ribosomes can queue behind the slow site. Collisions between ribosomes are not just passive traffic jams; in eukaryotes, collided ribosomes can recruit quality-control factors that trigger nascent-chain ubiquitination, ribosome rescue, and mRNA decay. In bacteria, rescue pathways such as trans-translation and alternative rescue factors act on stalled ribosomes. [Chapter 70](chapter1065.md) covers these quality-control pathways. The handoff matters because an elongation pause becomes biologically different once it produces a collision or activates surveillance.

Pausing also participates in cotranslational protein biogenesis. Slower translation at domain boundaries may give an emerging domain time to fold before the next segment appears. Synonymous codon changes can alter folding efficiency in some proteins without changing amino acid sequence, but such effects are not universal. A synonymous substitution may change elongation speed, mRNA structure, splicing, mRNA localization, miRNA targeting, or RNA-binding protein interactions. In coding regions, especially in eukaryotes, the mechanistic interpretation of a synonymous variant must separate these possibilities experimentally.

> **Box 68.1. How to Interpret a Ribosome Profiling Pause Peak**
>
> - Ask whether initiation rate changed at the upstream region, which would redistribute footprints independently of local elongation speed.
> - Ask whether ribosomes queued behind a slow site, because a queue creates density upstream of the actual slow codon.
> - Check whether inhibitor treatment during lysis created or shifted the peak relative to drug-free controls.
> - Test whether nuclease digestion conditions and read-length filters alter the peak position or height.
> - Perturb the proposed causal feature—such as a predicted mRNA structure or a rare codon cluster—and ask whether the peak changes as expected.
> - Measure mRNA abundance and total protein output so that translation efficiency and mRNA stability effects are not conflated with elongation dynamics.

## 68.4. Cotranslational folding and targeting

Cotranslational folding means that the protein product begins exploring conformations while still physically connected to the translation machinery. The nascent chain is synthesized from the N terminus to the C terminus. That directionality means the N-terminal part of a protein can emerge from the ribosome and fold before the C-terminal part exists. For a multidomain protein, one domain may fold while the next domain remains inside the tunnel or has not yet been synthesized. This vectorial order distinguishes cotranslational folding from refolding a full-length denatured protein in a test tube.

The ribosomal exit tunnel is not an inert pipe. It is a narrow passage through the large subunit, lined by rRNA and ribosomal proteins, that accommodates the nascent peptide before the peptide emerges into cytosol. The tunnel can allow limited secondary structure, especially alpha-helical segments, and it can sense peptide sequence. Positively charged, hydrophobic, or arrest-prone sequences can interact with tunnel components. These interactions can affect peptide-bond formation, elongation rate, and recruitment of factors. Structural and biochemical evidence reviewed by Korostelev supports a dynamic view in which the nascent chain and ribosome communicate across tens of angstroms.

Once a nascent chain emerges, it encounters chaperones and targeting factors. In bacteria, trigger factor binds near the ribosomal exit and helps shield nascent chains. In eukaryotes, ribosome-associated complex and nascent polypeptide-associated complex can influence folding and targeting, while Hsp70-family chaperones engage emerging chains. Morales-Polanco and colleagues review cotranslational protein biogenesis in eukaryotes, including complex assembly. A key concept is that cotranslational folding is not always aimed at forming a final isolated monomer. Some proteins assemble into complexes while being translated, and some nascent chains are handed to membranes, organelles, or degradation pathways.

Signal recognition particle provides the clearest RNA-linked targeting example. SRP is a ribonucleoprotein that recognizes hydrophobic signal sequences or transmembrane segments as they emerge from a translating ribosome. In bacteria, SRP contains a 4.5S RNA and the Ffh protein; in eukaryotes, SRP is larger and contains 7SL RNA plus multiple proteins. Recognition of a signal sequence creates a ribosome-nascent-chain-SRP complex. SRP and its receptor use coordinated GTPase cycles to target the complex to a membrane translocon. Zhang and Shan emphasize that SRP targeting has its own fidelity problem: the system must recognize appropriate substrates before translation proceeds too far, while rejecting proteins that should remain in the cytosol.

Targeting and elongation can influence each other. SRP binding can slow or pause elongation in some contexts, giving the targeting reaction time to occur. Membrane translocation can impose mechanical or folding constraints on the emerging chain. Secretory and membrane proteins may need to avoid premature cytosolic folding that would block translocation. Conversely, cytosolic proteins may benefit from local pauses that let domains fold before aggregation-prone segments emerge. The extent and universality of such timing mechanisms remain active topics, and claims should be tied to specific proteins, organisms, and assays.

Cotranslational folding is also linked to mRNA localization and local translation. In eukaryotic cells, some mRNAs are transported to subcellular regions before or during translation, so nascent chains are produced near their destination. The mRNA sequence therefore carries overlapping information: codons specify amino acids, untranslated regions recruit localization and regulatory factors, and coding-region features can affect elongation and folding. The same ribosome can be part of an mRNP life cycle involving localization, translation, decay, and quality control.

Evidence for cotranslational folding includes ribosome-nascent-chain cryo-EM structures, pulse-labeling, ribosome profiling, selective ribosome affinity purification, crosslinking, protease sensitivity, force measurements, and biochemical reconstitution. Each method has limits. A folded domain detected near ribosomes may fold cotranslationally or rapidly after release. A pause near a domain boundary may be functional or incidental. A chaperone crosslink may indicate proximity rather than productive folding assistance. Strong evidence usually combines temporal order, perturbation of elongation or chaperone binding, and a measurable protein-folding or targeting outcome.

## 68.5. Antibiotic and stress effects

Antibiotics and stress responses have been central tools for discovering elongation mechanisms because they trap ribosomes in otherwise transient states. Many antibacterial drugs target translation. Aminoglycosides can affect decoding fidelity; tetracyclines interfere with aminoacyl-tRNA entry; macrolides and related compounds bind in or near the exit tunnel; chloramphenicol inhibits peptide-bond formation; fusidic acid traps EF-G on bacterial ribosomes after GTP hydrolysis. These mechanisms are introduced here as textbook consensus; chapter-specific antibiotic references for these drug classes remain final-reference-expansion items before final publication.

Drug selectivity comes from structural differences among translation systems. A compound that binds bacterial rRNA may not bind eukaryotic cytosolic ribosomes with the same affinity. However, mitochondrial ribosomes derive from bacterial ancestors, so some antibiotics can impair mitochondrial translation and produce toxicity. Resistance can arise through rRNA modification, ribosomal protein mutations, efflux, drug-modifying enzymes, target protection proteins, or changes in membrane permeability. From an RNA perspective, antibiotic resistance often illustrates how a small change in rRNA sequence or modification state alters the chemical environment of a drug-binding pocket.

Cycloheximide is widely used to inhibit eukaryotic cytosolic elongation, but it is not a neutral pause button. It can freeze or redistribute ribosomes, alter footprint patterns, and interact with harvesting conditions. Harringtonine and lactimidomycin are often used to inhibit initiation or capture early elongation run-off, but their interpretations also require timing controls. Puromycin releases nascent chains by mimicking aminoacyl-tRNA, and emetine inhibits eukaryotic elongation. Experimental translation inhibitors can therefore reveal ribosome positions, but they can also create artifacts. Uematsu and Qian's discussion of interpreting ribosome dynamics is especially relevant: inhibitor choice, treatment time, lysis conditions, and analysis pipeline can change apparent elongation conclusions.

Cellular stress changes elongation through nutrient, signaling, and damage pathways. Amino acid starvation reduces charging of specific tRNAs, increasing ribosome dwell time at codons that require those tRNAs. Oxidative stress can damage RNA, proteins, or amino acids and may change translational fidelity. Heat shock increases the burden on chaperones and can make cotranslational folding more failure-prone. Endoplasmic reticulum stress changes translation through the integrated stress response and unfolded protein response. Viral infection can alter host translation factors, ribosome availability, and mRNA selection. Mohler and Ibba frame mistranslation as part of stress physiology, but stress effects should be interpreted at the level of specific mechanisms rather than as a generic reduction in accuracy.

> **Box 68.2. Synonymous Codons and Protein Biogenesis**
>
> - Synonymous codons encode the same amino acid but can differ in decoding speed depending on the abundance and charging state of the cognate tRNA.
> - The same nucleotide change that alters a codon can also alter mRNA secondary structure, splicing enhancers or silencers, mRNA localization signals, RNA-binding protein recognition sites, or mRNA stability.
> - A claim that a synonymous variant affects cotranslational folding requires evidence for altered protein folding or function, not only altered codon usage or elongation rate.
> - Synonymous recoding experiments should include controls for mRNA abundance, initiation efficiency, and mRNA localization to isolate elongation-specific effects.

Stress and antibiotics also connect elongation to quality control. Slow elongation can become ribosome stalling when a ribosome fails to make forward progress. Stalling can become ribosome collision when trailing ribosomes catch up. Collisions can recruit rescue and decay machinery. In eukaryotes, collided ribosomes are central triggers for ribosome-associated quality control; in bacteria, stalled ribosomes can be rescued by tmRNA-SmpB or alternative rescue factors. These responses protect cells from incomplete proteins and unavailable ribosomes, but they can also regulate gene expression by selectively destabilizing problematic mRNAs.

Boundary cases are important. A reduction in global protein synthesis during stress often reflects inhibited initiation rather than slowed elongation. A ribosome footprint increase on one region of an mRNA may reflect slower elongation, but it may also reflect selective stabilization of collided ribosomes or altered nuclease protection. Antibiotic treatment can increase apparent pausing at the drug's preferred sequence context, but physiological translation in untreated cells may not show the same pattern. For this reason, drug-treated datasets should be used as mechanistic perturbations, not as direct maps of normal elongation unless supported by drug-free controls.

## 68.6. Measurement by ribosome profiling and single-molecule methods

Ribosome profiling is a sequencing-based method that maps ribosome-protected mRNA fragments. The core idea is straightforward: ribosomes protect a short region of mRNA from nuclease digestion; protected fragments are purified, converted into sequencing libraries, and aligned to transcripts or genomes. Because footprints often show three-nucleotide periodicity over coding regions, ribosome profiling can identify translated open reading frames and estimate ribosome density. When calibrated carefully, changes in footprint density can suggest changes in initiation, elongation, termination, pausing, or ribosome rescue.

The hard part is interpretation. Ribosome density is not the same as elongation rate. At steady state, a region with many footprints may have slow elongation, high initiation feeding into that region, ribosome queues, or preferential nuclease protection. Footprint length and A-site assignment depend on ribosome conformation, species, nuclease, inhibitor, and computational pipeline. Highly structured RNAs, overlapping open reading frames, paralogous genes, and repetitive sequences can create mapping ambiguity. Watkins et al. and Uematsu and Qian emphasize that modern elongation measurements require careful design and cross-validation.

Several ribosome profiling variants try to extract dynamics. Run-off experiments block initiation and monitor how existing ribosomes leave coding sequences over time. Disome or collided-ribosome profiling isolates footprints protected by two ribosomes and is useful for studying collisions. Drug-specific profiling can enrich ribosomes at particular states, such as initiating ribosomes or stalled elongation complexes. Ribosome nascent-chain complex purification can connect footprints to chaperone binding or targeting factors. These approaches add information but also add perturbations; the experiment must match the question.

Single-molecule methods complement sequencing by observing individual translation complexes. Single-molecule FRET can monitor tRNA movement, factor binding, subunit rotation, or nascent-chain conformational changes. Optical tweezers can apply or measure forces during nascent-chain folding or translocation. Zero-mode waveguides and related fluorescence platforms can follow codon-by-codon translation on designed mRNAs. These methods can reveal heterogeneity hidden in bulk assays: two ribosomes translating the same sequence may pause for different times because molecular transitions are probabilistic.

The strength of single-molecule assays is also their limitation. To see a clean signal, experiments often use purified components, short mRNAs, immobilized complexes, fluorescent labels, nonphysiological factor concentrations, or simplified ionic conditions. Labels can perturb kinetics, and surface attachment can alter conformational freedom. The best single-molecule studies therefore interpret absolute rates cautiously and focus on mechanistic ordering, relative changes, and state transitions that can be compared with bulk biochemistry and cellular data.

Structural methods give a third view. Cryo-EM can classify ribosomes into many conformational states, including factor-bound, rotated, hybrid, stalled, collided, or nascent-chain-engaged states. Time-resolved cryo-EM and rapid mixing approaches can enrich intermediate states. Structural data are powerful for showing how an antibiotic binds, how a nascent peptide contacts the exit tunnel, or how a factor stabilizes a translocation intermediate. But a structural class abundance is not automatically a kinetic rate. Sample preparation, particle classification, and biochemical trapping can bias state populations.

A practical evidence hierarchy for elongation claims begins with precise language. If the claim is "codon X is slow," the supporting data should measure dwell time or infer it with controls for initiation and ribosome traffic. If the claim is "a synonymous variant changes folding," the evidence should show altered protein folding or function while controlling for mRNA abundance, localization, initiation, and amino acid sequence. If the claim is "an antibiotic induces miscoding," the evidence should include direct fidelity measurement rather than only growth inhibition. The field is strongest when sequencing, structural, kinetic, genetic, and proteomic evidence agree.

## Recent Consensus

Recent consensus treats elongation as a dynamic, multi-step process rather than a metronomic triplet-reading reaction. Conserved elongation factors deliver aminoacyl-tRNAs and drive translocation through GTP-dependent cycles. The ribosome uses RNA-rich structural centers to decode codons and catalyze peptide-bond formation. Fidelity emerges from tRNA charging, initial selection, induced fit, proofreading, and downstream protein quality control.

The field also agrees that elongation rate varies along transcripts and across conditions. Codon usage, tRNA availability, mRNA structure, nascent peptide sequence, and ribosome traffic can all contribute. However, there is no universal one-to-one mapping from codon rarity to slow elongation, nor from ribosome footprint density to dwell time. The most reliable studies combine perturbation, temporal measurements, and orthogonal validation.

Cotranslational folding and targeting are now central parts of translation biology. Nascent chains interact with the exit tunnel, chaperones, targeting factors, membranes, and assembly partners before release. SRP-mediated targeting illustrates how an RNA-protein particle can read a nascent peptide signal and coordinate translation with membrane delivery. Protein biogenesis begins during elongation, not after termination.

## Open Questions, Controversies, Deprecated Models, and Common Misconceptions

Open questions:

- How often are local elongation pauses evolved regulatory features rather than biochemical side effects? Some pauses are clearly programmed, but many observed pauses may reflect tRNA availability, structure, collisions, or experimental artifacts. Comparative genomics, synonymous recoding, and direct kinetic measurement are needed to separate adaptation from constraint.
- How general are codon-ramp models? Early coding regions often have unusual sequence properties, but the selective explanation can differ by organism, expression level, gene class, and measurement method. Ramping should be treated as a hypothesis for specific genes or systems unless supported by direct evidence.
- How much does synonymous variation affect cotranslational folding in natural settings? Some variants have strong effects on protein folding or function, but many synonymous changes act through mRNA abundance, splicing, localization, or translation initiation. The safe claim is that synonymous variants can affect protein biogenesis through several mechanisms, not that every codon change has a folding consequence.

Common misconceptions:

- "Rare codons always cause ribosome pausing." Rare codons can be slow in some contexts, but decoding depends on charged tRNA concentration, wobble, neighboring codons, mRNA structure, initiation rate, and stress state.
- "A ribosome profiling peak proves a regulatory pause." A peak is an observation requiring mechanistic explanation. It may reflect a pause, a queue, nuclease bias, inhibitor artifact, mapping ambiguity, or altered initiation.
- "Translation proofreading removes wrong amino acids from proteins." Ribosomal proofreading rejects tRNAs before peptide-bond formation. Once a wrong amino acid is incorporated, quality control acts on the resulting protein or ribosome state rather than reversing the peptide bond.